Europe CIS provides a broad range of Sterile Focus and Regional Brands while operating a range of manufacturing facilities for Aspen’s own production needs, as well as manufacturing for third parties. Sterile Focus Brands comprise anaesthetics and thrombosis in Russia and the other CIS countries only. Manufacturing activities include active pharmaceutical ingredients (“APIs”) and FDF production and our sites are widely accredited. The prefilled syringe and multi-dose form sites in France and Germany respectively, provide FDF medicines for commercialisation by Aspen and third parties for both domestic and export markets.
|Ovestin||Estrogen hormone replacement|
NUMBER OF PERMANENT EMPLOYEES
Number of products launched:
Number of product recalls:
Average staff turnover:
Number of work-related fatalities:
|Total Commercial Pharmaceuticals||5 314||5 653||(6)|
|Regional Brands||1 774||2 170||(18)|
|Sterile Focus Brands||3 540||3 483||2|
|Total Manufacturing||8 308||6 438||29|
|API Biochem||1 243||1 183||5|
|API Chemicals||4 817||4 548||6|
|Total||13 622||12 091||13|
Note: Commercial Pharmaceuticals revenue by customer geography and manufacturing revenue by place of manufacture.